Author

H. K. Gillespie

Observed names: H Gillespie, H K GILLESPIE, H K Gillespie, H. Gillespie, H. K. GILLESPIE, H.K. Gillespie, HK Gillespie, Hamp Gillespie, Hamp K. GILLESPIE, Hamp K. Gillespie, Hampton Gillespie, Hampton K. Gillespie

Observed institutions: United States Department of Veterans Affairs, VA Palo Alto Health Care System, Veterans Health Administration, Harris Health System, Karolinska Institutet, Palo Alto Veterans Institute for Research, Stanford Medicine, The University of Texas Health Science Center at Houston, Stanford University

OpenAlex ID: A5113972679

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

1980 · A Ohlsson, J-E Lindgren, et al. · Clinical Pharmacology & Therapeutics · 475

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

1986 · S Agurell, M Halldin, et al. · Pharmacological Reviews · 408

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration

1986 · Agneta Ohlsson, Jan-Erik Lindgren, et al. · Journal of Mass Spectrometry · 240

Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication

1996 · Nora D. Volkow, Hampton Gillespie, et al. · Psychiatry Research Neuroimaging · 219

Comparison of tetrahydrocannabinol and synhexyl in man

1968 · Leo E. Hollister, Richard K. Richards, et al. · Clinical Pharmacology & Therapeutics · 192

Brain glucose metabolism in violent psychiatric patients: a preliminary study

1995 · Nora D. Volkow, Lawrence R. Tancredib, et al. · Psychiatry Research Neuroimaging · 164

Do Plasma Concentrations of Δ9‐Tetrahydrocannabinol Reflect the Degree of Intoxication?

1981 · L. E. HOLLISTER, H. K. GILLESPIE, et al. · The Journal of Clinical Pharmacology · 163

Clinical effects and plasma levels of ?9-Tetrahydrocannabinol (?9-THC) in heavy and light users of cannabis

1981 · Jan-Erik Lindgren, Agneta Ohlsson, et al. · Psychopharmacology · 153

Marihuana and Temporal Disintegration

1970 · Frederick T. Melges, Jared R. Tinklenberg, et al. · Science · 139

Delta‐8‐ and delta‐9‐tetrahydrocannabinol; Comparison in man by oral and intravenous administration

1973 · Leo E. Hollister, H. K. Gillespie · Clinical Pharmacology & Therapeutics · 134

Aversive effects of naltrexone in subjects not dependent on opiates

1981 · Leo E. Hollister, Karen Johnson, et al. · Drug and Alcohol Dependence · 131

Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography

1981 · S. Agurell, S. Carlsson, et al. · Cellular and Molecular Life Sciences · 129

Single dose kinetics of deuterium labelled Δ1-tetrahydrocannabinol in heavy and light cannabis users

1982 · Agneta Ohlsson, Jan-Erik Lindgren, et al. · Journal of Mass Spectrometry · 120

Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: A study with positron emission tomography and 18F-2-Fluoro-2-deoxyglucose

1991 · Nora D. Volkow, Hampton Gillespie, et al. · Psychiatry Research Neuroimaging · 91

Marijuana and Immediate Memory

1970 · J. R. TINKLENBERG, F. T. MELGES, et al. · Nature · 89

Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiol

1975 · Leo E. Hollister, Hampton Gillespie · Clinical Pharmacology & Therapeutics · 84

Terminal elimination plasma half-life of ?1-tetrahydrocannabinol (?1-THC) in heavy users of marijuana

1989 · E. Johansson, M. M. Halldin, et al. · European Journal of Clinical Pharmacology · 67

A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepam

1978 · Shigeyuki Nakano, Hamp K. Gillespie, et al. · Clinical Pharmacology & Therapeutics · 60

An hallucinogenic amphetamine analog (DOM) in man

1969 · Leo E. Hollister, M. F. Macnicol, et al. · Psychopharmacology · 56

Clinical evaluation of a naltrexone sustained-release preparation

1985 · C.N. Chiang, L.E. Hollister, et al. · Drug and Alcohol Dependence · 53

Significance of blood sugar and serum electrolyte changes in cirrhosis following glucose, insulin, glucagon, or epinephrine.

1956 · T S DANOWSKI, H K GILLESPIE, et al. · Europe PMC (PubMed Central) · 40

Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking

1987 · Eva Johansson, Agneta Ohlsson, et al. · Journal of Mass Spectrometry · 35

Plasma concentrations of δ-9-tetrahydrocannabinol and impaired motor function

1983 · Victor C. Reeve, James D. Grant, et al. · Drug and Alcohol Dependence · 32

Single Dose Kinetics of Cannabidiol in Man

1984 · A. Ohlsson, J.E. Lindgren, et al. · Elsevier eBooks · 28

Theophylline antagonizes diazepam-induced psychomotor impairment

1983 · S. A. Henauer, L. E. Hollister, et al. · European Journal of Clinical Pharmacology · 27

Works count: 41

Citation count: 3,518

H-index: 25

I10-index: 35